Skip to content

Contact Us
Privacy/Terms
Join Our Team

Transforming Cancer Outcomes^TM

About Us
Technology & Proprietary Methodologies
Therapeutic Areas
- Malignant Gliomas
Pipeline
- IGV-001
Patients
News & Publications
Collaboration and Partnerships

Pipeline

Imvax > Pipeline

Share
Print

News

Stay informed about our latest
news and developments.

Patients

Our patients are the heart of our company, and they, along with their families, friends and caregivers, are just as much members of the Imvax Team.

601 Walnut St, Suite 440 W
Philadelphia, PA 19106

tel 267-900-4110

About Us
Leadership
Board of Directors
Scientific Advisors

Technology & Proprietary Methodologies
Patient Cell Harvest, Treatment, and Implant
Immunogenic Cell Death, Patient-Specific Antigens, Innate Immune System Activation
Long-term Adaptive Immune Activation and Response

Pipeline
IGV-001

Therapeutic Areas
Malignant Gliomas

close ×

Patients
News & Publications
Collaboration and Partnerships
Join Our Team

Website by Axxiem

© Copyright Imvax, Inc. All Right Reserved

Privacy/Terms | Sitemap